Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Biotechnology

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company`s lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn`s disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases which is in phase I clinical trials. In addition, the company develops CNS-penetrant NLRP3 inhibitors for the treatment of Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and multiple sclerosis. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.
Website: ventyxbio.com




Profitability: LTM EBITDA margin is negative, 0.0%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 60% of quarters (showing a gain of -$0.01 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -26.3% (LTM)

Entry Point: Share price is 1 570.9% higher than minimum and 70.1% lower than maximum for the last 3 years

Insiders: For the last 3 months insiders sold company shares on $0.5 mln (-0.114% of cap.)

Key Financials (Download financials)

Ticker: VTYX
Share price, USD:  (0.0%)13.97
year average price 4.48  


year start price 1.73 2025-02-09

min close price 0.84 2025-04-07

max close price 14.03 2026-01-23

current price 13.97 2026-02-08
Common stocks: 52 471 003

Dividend Yield:  0.0%
EV / Sales: 200.0x
Margin (EBITDA LTM / Revenue):
Fundamental value created in LTM:
Market Cap ($m): 733
Net Debt ($m): -40
EV (Enterprise Value): 693
Price to Book: 3.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-23prnewswire.com

Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc. - VTYX

2026-01-21globenewswire.com

Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their Rights

2026-01-13globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

2025-12-30globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

2025-12-02globenewswire.com

Ventyx Provides Clinical and Corporate Updates

2025-11-18zacks.com

VTYX Stock Skyrockets 156% in a Month: Here's What You Need to Know

2025-10-24seekingalpha.com

Ventyx Biosciences, Inc. (VTYX) Discusses Positive Phase II Results of VTX3232 in Obesity and Cardiovascular Risk Factors Transcript

2025-08-27globenewswire.com

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

2024-12-10globenewswire.com

VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

2024-09-24zacks.com

VTYX Stock Rises on Strategic Equity Investment Deal With SNY
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-05-09 2023-11-09 2023-08-10 2023-05-11 2022-11-04
acceptedDate 2025-11-06 16:10:49 2025-08-07 16:15:06 2025-02-27 17:21:44 2024-11-07 16:58:11 2024-08-08 16:15:39 2024-05-09 16:16:14 2024-02-27 16:15:34 2023-11-09 16:20:33 2023-08-10 16:16:55 2023-05-11 16:21:17 2023-03-23 16:17:35 2022-11-04 17:28:42 2022-03-23 17:49:26 2020-12-31 00:00:00
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0
costOfRevenue 0 0 0 0 316 000 408 000 0 265 000 139 000 0 0 0 0 0
grossProfit 0 0 0 0 -316 000 -408 000 0 -265 000 -139 000 0 0 0 0 0
grossProfitRatio 0 0 0 0 0 0 0 0 0
researchAndDevelopmentExpenses 18M 22M 117M 31M 28M 34M 176M 50M 49M 35M 88M 25M 58M 6M
generalAndAdministrativeExpenses 7M 7M 31M 8M 8M 8M 32M 8M 9M 7M 25M 6M 9M 684 000
sellingAndMarketingExpenses 0 0 0 0 -316 000 -408 000 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 7M 7M 31M 8M 8M 8M 32M 8M 9M 7M 25M 6M 9M 684 000
otherExpenses 0 0 0 0 -21 000 -31 000 0 -8000 -5000 -1000 0 0 0 0
operatingExpenses 25M 29M 148M 39M 35M 41M 208M 58M 57M 43M 113M 31M 67M 7M
costAndExpenses 25M 29M 148M 39M 36M 42M 208M 58M 57M 43M 113M 31M 67M 7M
interestIncome 2M 2M 13M 3M 4M 3M 15M -4M 4M 4M 5M 0 78 000 358
interestExpense 0 0 0 0 0 0 0 0 0 -4M 0 -958 000 99 000 358 000
depreciationAndAmortization 61 000 323 000 1M 309 000 316 000 408 000 941 000 265 000 139 000 134 000 470 000 1M 30 000 7M
ebitda -23M -29M -147M -38M -35M -41M -207M -58M -57M -43M -113M -30M -84M 0
ebitdaratio 0 0 0 0 0 0 0 0 0
operatingIncome -25M -29M -148M -39M -36M -42M -208M -58M -57M -43M -113M -31M -67M -7M
operatingIncomeRatio 0 0 0 0 0 0 0 0 0
totalOtherIncomeExpensesNet 2M 2M 13M 3M 4M 3M 15M 4M -5000 4M 5M 958 000 -17M -21M
incomeBeforeTax -23M -27M -135M -35M -32M -39M -193M -54M -53M -39M -108M -30M -84M -28M
incomeBeforeTaxRatio 0 0 0 0 0 0 0 0 0
incomeTaxExpense 0 0 0 0 0 364 724 0 -265 000 -4M -4M 0 -958 000 0 0
netIncome -23M -27M -135M -35M -32M -39M -193M -54M -53M -35M -108M -30M -84M -28M
netIncomeRatio 0 0 0 0 0 0 0 0 0
eps -0.32 -0.38 -1.97 -0.5 -0.45 -0.62 -3.3 -0.92 -0.91 -0.61 -2.06 -0.57 -1.69 -0.56
epsdiluted -0.32 -0.38 -0.5 -0.45 -0.62 -0.92 -0.91 -0.61 -0.57
weightedAverageShsOut 71M 71M 68M 71M 71M 62M 59M 59M 59M 58M 52M 52M 50M 50M
weightedAverageShsOutDil 71M 71M 68M 71M 71M 62M 59M 59M 59M 58M 52M 52M 50M 50M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-27 2023-03-23 2022-03-24 2020-12-31
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 13M 15M 5M -21 000 -357 642
ebit -148M -208M -113M -84M -7M
nonOperatingIncomeExcludingInterest 0 0 0 17M 0
netIncomeFromContinuingOperations -135M -193M -108M -84M -28M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -135M -193M -108M -85M -28M
epsDiluted -1.97 -3.3 -2.06 -1.69 -0.56

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-05-09 2023-11-09 2023-08-10 2023-05-11 2022-11-04
acceptedDate 2025-11-06 16:10:49 2025-08-07 16:15:06 2025-02-27 17:21:44 2024-11-07 16:58:11 2024-08-08 16:15:39 2024-05-09 16:16:14 2024-02-27 16:15:34 2023-11-09 16:20:33 2023-08-10 16:16:55 2023-05-11 16:21:17 2023-03-23 16:17:35 2022-11-04 17:28:42 2022-03-23 17:49:26 2020-12-31 00:00:00
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 32M 32M 27M 62M 41M 142M 52M 57M 52M 64M 65M 263M 71M 244 000
shortTermInvestments 161M 177M 190M 213M 199M 161M 201M 244M 281M 313M 253M 149M 188M 0
cashAndShortTermInvestments 193M 209M 217M 275M 239M 303M 252M 301M 332M 377M 318M 412M 259M 244 000
netReceivables 0 1 000 000 1 000 000 0 0 600 000 0 0 0 49 000 0 0 0 0
inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherCurrentAssets 8M 9M 11M 15M 17M 17M 12M 7M 14M 10M 13M 6M 0 0
totalCurrentAssets 201M 219M 230M 289M 257M 320M 264M 308M 347M 387M 331M 418M 263M 245 000
propertyPlantEquipmentNet 9M 10M 10M 11M 11M 11M 12M 13M 2M 2M 2M 2M 254 000 0
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
goodwillAndIntangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
longTermInvestments 0 975 000 36M 0 41M 975 000 0 975 000 0 0 39M 0 28M 0
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 987 000 12 000 1M 1M 102 000 101 999 1M 102 000 102 000 96 000 96 000 72 000 60 000 0
totalNonCurrentAssets 10M 11M 47M 12M 52M 12M 13M 14M 2M 2M 41M 2M 28M 0
otherAssets 0 0 0 0 1 1 0 -0 0 0 0 0 0 0
totalAssets 211M 230M 277M 301M 309M 332M 278M 322M 349M 389M 371M 420M 291M 245 000
accountPayables 993 000 913 000 3M 2M 7M 6M 6M 9M 4M 7M 6M 19M 5M 1M
shortTermDebt 1M 1M 0 0 2M 946 000 0 479 000 439 000 426 000 0 395 000 0 0
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherCurrentLiabilities 9M 9M 0 10M 10M 8M 0 16M 16M 10M 0 17M 0 0
totalCurrentLiabilities 11M 11M 13M 12M 18M 15M 22M 26M 20M 17M 16M 36M 12M 1M
longTermDebt 9M 9M 0 10M 10M 11M 0 12M 922 000 1M 0 1M 0 13M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 0 0 0 0 0 0 0 0 0 0 0 -18M 0 17M
totalNonCurrentLiabilities 9M 9M 10M 10M 10M 11M 12M 12M 922 000 1M 1M 1M 0 29M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 10M 10M 11M 10M 11M 11M 13M 12M 1M 1M 2M 2M 0 0
totalLiabilities 20M 21M 23M 22M 28M 25M 34M 38M 21M 18M 18M 37M 12M 31M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 7000 7000 7000 7000 7000 7000 6000 6000 6000 6000 6000 6000 5000 0
retainedEarnings -632M -609M -554M -525M -490M -458M -419M -372M -318M -265M -226M -191M -118M -33M
accumulatedOtherComprehensiveIncomeLoss 223 000 248 000 157 000 873 000 -248 000 -121 000 -50 000 -507 000 -710 000 -561 000 -1M -1M -58 000 0
othertotalStockholdersEquity 823M 818M 803M 771M 765M 657M 647M 555 000 576M
totalStockholdersEquity 191M 209M 254M 279M 281M 307M 244M 284M 328M -265M 354M 384M 279M -31M
totalEquity 191M 209M 254M 279M 281M 307M 244M 284M 328M -265M 354M 384M 279M -31M
totalLiabilitiesAndStockholdersEquity 211M 230M 301M 309M 332M 322M 349M -248M 420M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 211M 230M 277M 301M 309M 332M 278M 322M 349M -248M 371M 420M 291M 245 000
totalInvestments 161M 178M 226M 213M 240M 162M 201M 244M 281M 313M 292M 149M 216M 0
totalDebt 10M 10M 11M 11M 11M 11M 13M 12M 1M 1M 2M 2M 0 13M
netDebt -22M -22M -16M -51M -30M -130M -39M -44M -50M -62M -63M -262M -71M 12M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-27 2023-03-23 2022-03-24 2020-12-31
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 0 0 0 0 0
otherReceivables 1 000 000 0 0 0 0
prepaids 0 0 0 4M 1000
totalPayables 3M 6M 6M 5M 1M
otherPayables 0 0 0 0 0
accruedExpenses 9M 16M 10M 8M 301 000
capitalLeaseObligationsCurrent 1M 1M 412 000 0 0
capitalLeaseObligationsNonCurrent 10M 12M 1M 0 0
treasuryStock 0 0 0 0 0
additionalPaidInCapital 808M 663M 581M 397M 2M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX VTYX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-05-09 2023-11-09 2023-08-10 2023-05-11 2022-11-04
acceptedDate 2025-11-06 16:10:49 2025-08-07 16:15:06 2025-02-27 17:21:44 2024-11-07 16:58:11 2024-08-08 16:15:39 2024-05-09 16:16:14 2024-02-27 16:15:34 2023-11-09 16:20:33 2023-08-10 16:16:55 2023-05-11 16:21:17 2023-03-23 16:17:35 2022-11-04 17:28:42 2022-03-23 17:49:26 2020-12-31 00:00:00
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -23M -27M -135M -35M -32M -39M -193M -54M -53M -39M -108M -30M -84M -28M
depreciationAndAmortization 326 000 323 000 1M 309 000 316 000 408 000 941 000 265 000 139 000 134 000 470 000 127 000 30 000 0
deferredIncomeTax 0 0 0 0 0 0 0 0 0 0 0 0 0 0
stockBasedCompensation 5M 5M 23M 5M 6M 7M 29M 8M 8M 7M 17M 4M 3M 45 000
changeInWorkingCapital 1M 2M -11M 10M 4M -14M 6M 13M -2M 3M -5M 3M 4M 812 000
accountsReceivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0
accountsPayables 101 000 -1M -3M -4M 2M -1M -745 000 5M -2M -91 000 2M 9M 2M 591 000
otherWorkingCapital 1M 4M -8M 14M 2M -13M 7M 8M 733 000 91 000 -7M -6M 2M 221 000
otherNonCashItems -1M -1M -9M -16M 2M 7M -9M -2M -2M -2M -2M -386 000 38M 21M
netCashProvidedByOperatingActivities -18M -21M -131M -35M -25M -48M -167M -35M -49M -31M -99M -24M -39M -6M
investmentsInPropertyPlantAndEquipment -50 000 -42 000 -241 000 0 -60 000 -175 000 -514 000 -48 000 -195 000 -60 000 -275 000 -97 000 -262 000 0
acquisitionsNet 0 0 0 0 0 0 0 -38 939 -35 014 0 74 656 0 2M 0
purchasesOfInvestments -35M -34M -284M -32M -151M -25M -272M -71M -64M -109M -347M -17M -233M 0
salesMaturitiesOfInvestments 52M 59M 268M 62M 75M 67M 374M 110M 99M 90M 273M 81M 17M 0
otherInvestingActivites 0 0 0 -75M 42M 38 939 35 014 0 0
netCashUsedForInvestingActivites 17M 25M 29M -76M 42M 39M 35M -19M 64M
debtRepayment 0 0 0 0 0 0 0 0 0
commonStockIssued 0 0 -232 000 -906 000 96M 2M -47 000 48M 0
commonStockRepurchased 0 68 000 0 1M -906 000 0 0 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites 203 000 0 27M 140 000 92 000 -78 000 3M 191 000 178M
netCashUsedProvidedByFinancingActivities 203 000 68 000 27M -906 000 96M 2M 2M 49M 178M
effectOfForexChangesOnCash -77 000 242 000 -55 000 192 000 -9000 -5000 -12 000 16 000 38 000 20 000 -42 000 -38 000 11 000 0
netChangeInCash -331 000 4M -24M 22M -101M 90M -12M 6M -12M -1M -6M 218M 71M -65 000
cashAtEndOfPeriod 33M 33M 28M 63M 41M 142M 53M 58M 52M 64M 65M 263M 71M 244 000
cashAtBeginningOfPeriod 33M 29M 53M 41M 142M 52M 65M 52M 64M 65M 71M 45M 244 000 309 000
operatingCashFlow -18M -21M -131M -35M -25M -48M -167M -35M -49M -31M -99M -24M -39M -6M
capitalExpenditure -50 000 -42 000 -241 000 0 -60 000 -175 000 -514 000 -48 000 -195 000 -60 000 -275 000 -97 000 -262 000 0
freeCashFlow -18M -21M -131M -35M -25M -48M -167M -35M -49M -31M -99M -24M -39M -6M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-27 2023-03-23 2022-03-24 2020-12-31
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 -74 656 0 0
netCashProvidedByInvestingActivities -16M 101M -75M -214M 0
netDebtIssuance 0 0 0 450 000 6M
longTermNetDebtIssuance 0 0 0 450 000 6M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 122M 48M 165M 323M 2000
netCommonStockIssuance 95M 48M 165M 159M 2000
commonStockIssuance 95M 48M 165M 159M 2000
netPreferredStockIssuance 27M 0 0 164M 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 466 000 5M 2M 65 000 0
netCashProvidedByFinancingActivities 122M 53M 168M 324M 6M
incomeTaxesPaid 0 0 0 3000 1000
interestPaid 0 0 0 0 0

Earning call transcript

2024 q1
2024-05-11 ET (fiscal 2024 q1)
2023 q2
2023-08-13 ET (fiscal 2023 q2)
2023 q1
2023-05-14 ET (fiscal 2023 q1)
2022 q4
2023-03-23 ET (fiscal 2022 q4)
2022 q3
2022-11-06 ET (fiscal 2022 q3)
2022 q2
2022-08-16 ET (fiscal 2022 q2)
2022 q1
2022-05-13 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2026-01-07 22:02 ET
Ventyx Biosciences, Inc. published news for 2025 q4
SEC form 8
2026-01-07 22:02 ET
Ventyx Biosciences, Inc. published news for 2025 q4
SEC form 8
2026-01-07 22:02 ET
Ventyx Biosciences, Inc. published news for 2025 q4
SEC form 8
2026-01-07 22:02 ET
Ventyx Biosciences, Inc. published news for 2025 q4
SEC form 10
2025-11-06 16:10 ET
Ventyx Biosciences, Inc. reported for 2025 q3
SEC form 8
2025-11-06 16:05 ET
Ventyx Biosciences, Inc. published news for 2025 q3
SEC form 8
2025-11-06 16:05 ET
Ventyx Biosciences, Inc. published news for 2025 q3
SEC form 8
2025-10-22 20:19 ET
Ventyx Biosciences, Inc. published news for 2025 q3
SEC form 8
2025-10-22 20:19 ET
Ventyx Biosciences, Inc. published news for 2025 q3
SEC form 8
2025-10-22 20:19 ET
Ventyx Biosciences, Inc. published news for 2025 q3
SEC form 10
2025-08-07 20:15 ET
Ventyx Biosciences, Inc. reported for 2025 q2
SEC form 8
2025-08-07 20:09 ET
Ventyx Biosciences, Inc. published news for 2025 q2
SEC form 8
2025-08-07 20:09 ET
Ventyx Biosciences, Inc. published news for 2025 q2
SEC form 8
2025-06-17 12:00 ET
Ventyx Biosciences, Inc. published news for 2025 q1
SEC form 8
2025-06-17 12:00 ET
Ventyx Biosciences, Inc. published news for 2025 q1
SEC form 10
2025-05-08 20:15 ET
Ventyx Biosciences, Inc. reported for 2025 q1
SEC form 8
2025-05-08 20:05 ET
Ventyx Biosciences, Inc. published news for 2025 q1
SEC form 8
2025-05-08 20:05 ET
Ventyx Biosciences, Inc. published news for 2025 q1
SEC form 10
2025-05-08 00:00 ET
Ventyx Biosciences, Inc. reported for 2025 q1
SEC form 10
2025-02-27 22:21 ET
Ventyx Biosciences, Inc. reported for 2024 q4
SEC form 10
2025-02-27 00:00 ET
Ventyx Biosciences, Inc. reported for 2024 q4
SEC form 8
2025-02-27 00:00 ET
Ventyx Biosciences, Inc. published news for 2024 q4
SEC form 8
2025-02-27 00:00 ET
Ventyx Biosciences, Inc. published news for 2024 q4
SEC form 8
2025-01-14 00:00 ET
Ventyx Biosciences, Inc. published news for 2024 q4
SEC form 8
2025-01-14 00:00 ET
Ventyx Biosciences, Inc. published news for 2024 q4
SEC form 8
2025-01-14 00:00 ET
Ventyx Biosciences, Inc. published news for 2024 q4
SEC form 10
2024-11-07 16:58 ET
Ventyx Biosciences, Inc. reported for 2024 q3
SEC form 8
2024-11-07 16:10 ET
Ventyx Biosciences, Inc. published news for 2024 q3
SEC form 8
2024-11-07 16:10 ET
Ventyx Biosciences, Inc. published news for 2024 q3
SEC form 10
2024-08-08 16:15 ET
Ventyx Biosciences, Inc. reported for 2024 q2
SEC form 10
2024-08-08 00:00 ET
Ventyx Biosciences, Inc. reported for 2024 q2
SEC form 8
2024-08-08 00:00 ET
Ventyx Biosciences, Inc. published news for 2024 q2
SEC form 8
2024-08-08 00:00 ET
Ventyx Biosciences, Inc. published news for 2024 q2
SEC form 10
2024-05-09 00:00 ET
Ventyx Biosciences, Inc. reported for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Ventyx Biosciences, Inc. published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Ventyx Biosciences, Inc. published news for 2024 q1
SEC form 10
2024-02-27 16:15 ET
Ventyx Biosciences, Inc. reported for 2023 q4
SEC form 10
2024-02-27 00:00 ET
Ventyx Biosciences, Inc. reported for 2023 q4
SEC form 8
2024-02-27 00:00 ET
Ventyx Biosciences, Inc. published news for 2023 q4
SEC form 8
2024-02-27 00:00 ET
Ventyx Biosciences, Inc. published news for 2023 q4
SEC form 10
2023-11-09 16:20 ET
Ventyx Biosciences, Inc. reported for 2023 q3
SEC form 10
2023-11-09 00:00 ET
Ventyx Biosciences, Inc. reported for 2023 q3
SEC form 8
2023-11-09 00:00 ET
Ventyx Biosciences, Inc. published news for 2023 q3
SEC form 8
2023-11-06 00:00 ET
Ventyx Biosciences, Inc. published news for 2023 q3
SEC form 10
2023-08-10 16:16 ET
Ventyx Biosciences, Inc. reported for 2023 q2
SEC form 6
2023-08-10 16:07 ET
Ventyx Biosciences, Inc. reported for 2023 q2
SEC form 10
2023-08-10 00:00 ET
Ventyx Biosciences, Inc. reported for 2023 q2
SEC form 8
2023-08-10 00:00 ET
Ventyx Biosciences, Inc. reported for 2023 q2
SEC form 6
2023-07-25 18:58 ET
Ventyx Biosciences, Inc. published news for 2023 q2
SEC form 10
2023-05-11 16:21 ET
Ventyx Biosciences, Inc. reported for 2023 q1
SEC form 6
2023-05-11 16:07 ET
Ventyx Biosciences, Inc. reported for 2023 q1
SEC form 10
2023-05-11 00:00 ET
Ventyx Biosciences, Inc. reported for 2023 q1
SEC form 8
2023-05-11 00:00 ET
Ventyx Biosciences, Inc. reported for 2023 q1
SEC form 6
2023-04-26 16:16 ET
Ventyx Biosciences, Inc. published news for 2023 q1
SEC form 6
2023-04-13 17:45 ET
Ventyx Biosciences, Inc. published news for 2023 q1
SEC form 10
2023-03-23 16:17 ET
Ventyx Biosciences, Inc. reported for 2022 q4
SEC form 6
2023-03-23 16:05 ET
Ventyx Biosciences, Inc. reported for 2022 q4
SEC form 10
2023-03-23 00:00 ET
Ventyx Biosciences, Inc. reported for 2022 q4
SEC form 8
2023-03-23 00:00 ET
Ventyx Biosciences, Inc. reported for 2022 q4
SEC form 6
2023-01-26 16:07 ET
Ventyx Biosciences, Inc. published news for 2022 q4
SEC form 6
2023-01-12 17:09 ET
Ventyx Biosciences, Inc. published news for 2022 q4
SEC form 6
2023-01-12 17:01 ET
Ventyx Biosciences, Inc. published news for 2022 q4
SEC form 6
2023-01-12 16:05 ET
Ventyx Biosciences, Inc. published news for 2022 q4
SEC form 6
2022-12-20 16:54 ET
Ventyx Biosciences, Inc. published news for 2022 q3
SEC form 6
2022-12-12 17:00 ET
Ventyx Biosciences, Inc. published news for 2022 q3
SEC form 6
2022-11-30 16:37 ET
Ventyx Biosciences, Inc. published news for 2022 q3
SEC form 10
2022-11-04 17:28 ET
Ventyx Biosciences, Inc. reported for 2022 q3
SEC form 10
2022-11-04 00:00 ET
Ventyx Biosciences, Inc. reported for 2022 q3
SEC form 6
2022-11-03 16:10 ET
Ventyx Biosciences, Inc. reported for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Ventyx Biosciences, Inc. reported for 2022 q3
SEC form 6
2022-09-19 08:10 ET
Ventyx Biosciences, Inc. published news for 2022 q2
SEC form 10
2022-08-15 16:46 ET
Ventyx Biosciences, Inc. reported for 2022 q2
SEC form 6
2022-08-15 16:32 ET
Ventyx Biosciences, Inc. reported for 2022 q2
SEC form 10
2022-08-15 00:00 ET
Ventyx Biosciences, Inc. reported for 2022 q2
SEC form 8
2022-08-15 00:00 ET
Ventyx Biosciences, Inc. reported for 2022 q2
SEC form 6
2022-06-29 08:30 ET
Ventyx Biosciences, Inc. published news for 2022 q1
SEC form 6
2022-06-09 16:37 ET
Ventyx Biosciences, Inc. published news for 2022 q1
SEC form 10
2022-05-12 16:28 ET
Ventyx Biosciences, Inc. reported for 2022 q1
SEC form 6
2022-05-12 16:09 ET
Ventyx Biosciences, Inc. published news for 2022 q1
SEC form 10
2022-05-12 00:00 ET
Ventyx Biosciences, Inc. reported for 2022 q1
SEC form 8
2022-05-12 00:00 ET
Ventyx Biosciences, Inc. reported for 2022 q1
SEC form 6
2022-05-09 08:23 ET
Ventyx Biosciences, Inc. published news for 2022 q1
SEC form 6
2022-05-09 08:07 ET
Ventyx Biosciences, Inc. published news for 2022 q1
SEC form 6
2022-04-27 16:10 ET
Ventyx Biosciences, Inc. published news for 2022 q1
SEC form 10
2022-03-24 00:00 ET
Ventyx Biosciences, Inc. published news for 2021 q4
SEC form 10
2022-03-23 17:49 ET
Ventyx Biosciences, Inc. published news for 2021 q4
SEC form 6
2022-03-23 08:15 ET
Ventyx Biosciences, Inc. published news for 2021 q4
SEC form 8
2022-03-23 00:00 ET
Ventyx Biosciences, Inc. published news for 2021 q4
SEC form 6
2022-03-15 06:07 ET
Ventyx Biosciences, Inc. published news for 2021 q4
SEC form 6
2021-11-30 16:06 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 10
2021-11-18 00:00 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 10
2021-11-17 20:35 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-11-17 16:23 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-25 17:09 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-20 18:53 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-20 18:50 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-20 18:48 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-20 18:48 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-20 18:47 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-20 18:47 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-20 18:45 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-20 18:44 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-20 18:43 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-20 18:42 ET
Ventyx Biosciences, Inc. published news for 2021 q3
SEC form 6
2021-10-20 18:41 ET
Ventyx Biosciences, Inc. published news for 2021 q3